April 3 – A study is published in the New England Journal of Medicine titled, “Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.” The study concluded, “The time to sustained alleviation of all signs and symptoms of Covid-19 did not differ significantly between participants who received nirmatrelvir-ritonavir and those who received placebo.” About a month ago (March 4th) a separate study found the same thing – namely that Paxlovid is ineffective, overpriced garbage. Also see this.
April 5 – A study is published on Science Direct titled, “Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?” While the full text of the study is behind a paywall, the abstract and a few “snippets” are available to read. The abstract reads in part, “Mounting evidence indicates that these vaccines [mRNA vaccines], like many others, do not generate sterilizing immunity, leaving people vulnerable to recurrent infections. Additionally, it has been discovered that the mRNA vaccines inhibit essential immunological pathways, thus impairing early interferon signaling. Within the framework of COVID-19 vaccination, this inhibition ensures an appropriate spike protein synthesis and a reduced immune activation. Evidence is provided that adding 100% of N1-methyl-pseudouridine (m1Ψ) to the mRNA vaccine in a melanoma model stimulated cancer growth and metastasis, while non-modified mRNA vaccines induced opposite results, thus suggesting that COVID-19 mRNA vaccines could aid cancer development. Based on this compelling evidence, we suggest that future clinical trials for cancers or infectious diseases should not use mRNA vaccines with a 100% m1Ψ modification, but rather ones with the lower percentage of m1Ψ modification to avoid immune suppression.”
April 7 – A study is published in Frontiers titled, “Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial.” The goal was to discover whether treating COVID patients with a high dose of spirulina (15.2 grams via capsules) in addition to the “standard” treatment would be safe and effective. Nearly 200 people participated in the week-long randomized, controlled trial and the level of success was measured by looking at mortality and hospital discharge within the seven days. According to the results, “there were no deaths in the Spirulina group, while 15 deaths (15.3%) occurred in the control group. Moreover, within seven days, there was a greater number of patients discharged in the Spirulina group (97.7%) in non-ICU compared to the control group (39.1%)… Overall mortality was higher in the control group (8.7% non-ICU, 28.8% ICU) compared to the Spirulina group (non-ICU HR, 0.13; 95% CI, 0.02 to 0.97; ICU, HR, 0.16; 95% CI, 0.05 to 0.48). In non-ICU, patients who received Spirulina showed a significant reduction in the levels of IL-6, TNF-α, IL-10, and IP-10 as intervention time increased…. No side effects related to Spirulina supplements were observed during the trial.” The study ultimately concluded, “High-dose Spirulina supplements coupled with the standard treatment of COVID-19 may improve recovery and remarkably reduce mortality in hospitalized patients with COVID-19.” Also see this.
April 8 – A study is published in Cureus titled, “Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan.” The authors first establish how the age-adjusted mortality rates for all cancers had been trending downward through the first year of the pandemic and up to the rollout of the COVID “vaccine.” At that point, significant increases in excess mortality began showing up among people ages 75-84 – who, coincidentally of course – had a booster rate of over 90%. According to the authors’ conclusions, “Statistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japanese population had received the third or later dose of SARS-CoV-2 mRNA-LNP [lipid nanoparticle] vaccine. These particularly marked increases in mortality rates of these ERα-sensitive cancers may be attributable to several mechanisms of the mRNA-LNP vaccination rather than COVID-19 infection itself or reduced cancer care due to the lockdown. The significance of this possibility warrants further studies.” The study includes an interesting section about how the body’s cancer immunosurveillance responses are suppressed following the introduction of a mRNA-LNP “vaccine” into the body. To make their case, the authors cite a series of studies that document this connection. Also see this and this.
April 17 – Jordan Schachtel publishes a breakdown of a recently-released HHS study showing a causal relationship between Pfizer and Moderna’s mRNA COVID clot shots and myocarditis. Schachtel writes in part, “the report only studies myocarditis resulting from the *first two mRNA Covid shot doses.* This report does not even get into the potential negative implications of the endless booster shot protocol, though it does cite studies that show there is a substantially increased risk of acquiring myocarditis from dose one to dose two. Nonetheless, in February of this year, the CDC’s vaccine review panel authorized the ninth mRNA dose for loyal Followers of the Science. Neither Pfizer nor Moderna have ever claimed to resolve the myocarditis issue with their injections. Nonetheless, government regulatory bodies continue to rubber stamp approval for the latest ‘booster’ shots from Pfizer and Moderna, despite the increasing risk of acquiring myocarditis with every additional shot. In justifying the increased risk for adverse events, advocates for the shots frequently advance the notion that acquiring myocarditis from mRNA vaccines is more rare than acquiring it from a coronavirus infection. This leads uninformed consumers to conduct an improper risk-benefit analysis, because there is no evidence that the shots prevent infection.”
April 23 – A preprint study is published at Authorea titled, “Oncogenesis and autoimmunity as a result of mRNA COVID-19 vaccination.” The abstract reads, “When an antigen stimulates the immune system, specific T regulatory (Treg) and T effector (Teff) subpopulations develop from naïve T cells. An inappropriate homeostatic balance among Teff, Treg and mTreg cells can direct the immune system toward either cancer or autoimmunity. When cancer is present, Treg cells suppress anti-tumor immunity, and, when cancer is absent, Treg cells play the beneficial role of preventing the development of autoimmunity. In this review, we analyze Treg responses after SARS-CoV-2 mRNA vaccination and find distinct pathological responses under differing conditions. In cancer patients, the degree of disease progression depends on the cancer status at the time of vaccination and the type of cancer treatment they receive concurrently. We hypothesize that migration of circulating dendritic cells and mTreg cells back to the thymus accelerates thymic involution [thymus shrinking and changing with age], a direct cause of immunosenescence [immune system declining over time]. In summary, the Treg responses produced after mRNA vaccination and the subsequent mRNA-encoded SARS-CoV-2 spike protein expression may lead to a harmful influence on the immune system of vaccinees, and subsequent accelerated development of cancer and autoimmune disease. These mechanisms are consistent with both epidemiological findings and case reports.”
The conclusion reads, “In this paper, we have provided an extensive review of the role of Treg cells in the immune system, with a particular focus on the apparent disruption of their behavior caused by the mRNA vaccines. It appears that the vaccines typically induce an intense IgG antibody response due to the toxicity of the spike protein, along with an extreme inflammatory response through cytokine release by T cells, and, ultimately, the potential for autoantibodies to attack the tissues through recognition of non-self spike protein on the cell surface. Because a natural infection is replaced by an abnormal situation in which human cells are producing large quantities of a toxic viral protein, the type I IFN response is suppressed. Normally, this response to double-stranded viral RNA induces the clonal expansion of a pool of Treg cells, but also keeps them suppressed until the viral load has sufficiently subsided. The mRNA in the vaccines is resistant to breakdown and concealed from the immune system due to its humanized code. This causes an unnatural and often inappropriate immune response, where the consequences are highly dependent on the prior immune state of the vaccinated individual, particularly with respect to their Treg cell population. Some of the activated DCs [dendritic cells] return to the thymus and induce a response that damages the thymic epithelium and accelerates thymic involution, leading to inflammaging and immunosenescence. This can also induce a life-threatening macrophage activation syndrome (HLH), as was observed in several case studies on the mRNA vaccines. Repeated booster vaccination can lead to the development of self-tolerance to the spike protein, which may make the person less resistant to the virus than a fully unvaccinated person.
We have analyzed the response to the mRNA vaccines against COVID-19 differentially depending on a distinction between cancer(-) and cancer(+) populations. The mRNA vaccines cause a Treg dysregulation in both populations. The Treg dysregulation in the cancer(-) population predominantly causes immune senescence and promotes autoimmunity, in part due to homing of mTreg cells to the thymus and accelerated thymic involution. In cancer(+) cases, depending in part upon whether they receive PD-1/PD-L1 inhibitors, the patients develop a hyperimmune response and also have a tendency to develop autoimmunity. Moreover, the cancer(+) patients who do not receive PD-1/PD-L1 blockers are prone to cancer progression by the mRNA vaccines. Furthermore, the development of a high Th17 response may also result in tumorigenesis, and, therefore, further studies are needed to evaluate the potential of the mRNA vaccines to induce cancer. The inhibition of mTOR may accelerate immunosenescence due to enhancement of the memory Teff response, and this is especially dangerous for the elderly population receiving the mRNA vaccines, who are at risk for both autoimmune and neoplastic disease.”
April 29 – A preprint study is published out of the Cleveland Clinic showing the more a person is “vaccinated” against COVID, the more susceptible to COVID they become. According to the study’s conclusion, “The 2023-2024 formula COVID-19 vaccine given to working-aged adults afforded a low level of protection against the JN.1 lineage of SARS-CoV-2, but a higher number of prior vaccine doses was associated with a higher risk of COVID-19.” Researchers found those who took two or more doses in the past were 1.46 times more at risk for COVID compared to those who took one dose or none at all. Those who took three shots were 1.95 times more likely to get sick, and those who took more than three doses were 2.51 times more likely. The study looked at the health outcomes of over 47K Cleveland Clinic employees over the span of 16 weeks (838 employees, or 1.8%, came down with COVID during that time).
May 8 – A study is published in Methods and Protocols titled, “Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty®.” Researchers found “Comirnaty contains DNA impurities that exceed the permitted limit value by several hundred times and, in some cases, even more than 500 times, and that this went unnoticed because the DNA quantification carried out as part of batch testing only at the active substance level appears to be methodologically inadequate when using qPCR [quantitative PCR]… Because of the conditions during the production of the mRNA active substance of Comirnaty, the applied qPCR is designed so that a massive under-detection of DNA impurities appears to be the result… Further, it should also be taken into account that DNA impurities in Comirnaty® are apparently integrated into the lipid nanoparticles and are thus transported directly into the cells of a vaccinated person, just like the mRNA active ingredient. What this means for the safety risks, particularly the possible integration of this DNA into the human genome, i.e., the risk of insertional mutagenesis, should be a secondary focus of the discussion required, which must go far beyond what could have been considered years before the so unexpected introduction of mRNA pharmaceuticals into the global market.” Also see this.
May 21 – A study is published in Frontiers in Pharmacology titled, “COVID-19 vaccination-related tinnitus is associated with pre-vaccination metabolic disorders.” Researchers analyzed the results of a survey taken by 398 individuals (263 females, 122 males, 13 unreported) who reported tinnitus post-vax, and sifted through the nearly 670K cases reported on VAERS between January 1, 2020 and November 26, 2021 – 12,532 of which were cases of tinnitus related to the COVID vaccine. The study determined, “following COVID-19 vaccination, 1) tinnitus report frequencies for Pfizer, Moderna and Janssen vaccines in VAERS are 47, 51 and 70 cases per million full vaccination; 2) the symptom onset was often rapid; 3) more women than men reported tinnitus and the sex difference increased with age; 4) for 2-dose vaccines, the frequency of tinnitus was higher following the first dose than the second dose; 5) for 2-dose vaccines, the chance of worsening tinnitus symptoms after second dose was approximately 50%; 6) tinnitus was correlated with other neurological and psychiatric symptoms; 7) pre-existing metabolic syndromes were correlated with the severity of the reported tinnitus. These findings suggest that COVID-19 vaccination increases the risk of tinnitus, and metabolic disorders is a risk factor for COVID-19 vaccination-related tinnitus.”
May 27 – A preprint study is published online titled, “Excess Cardiopulmonary Arrest and Mortality after COVID-19 Vaccination in King County, Washington.” By 2023, this Washington county boasted a COVID vaccination rate of 98%. The analysis “revealed a 25.7% increase in total cardiopulmonary arrests and a 25.4% increase in cardiopulmonary arrest mortality from 2020 to 2023 in King County, WA. Excess cardiopulmonary arrest deaths were estimated to have increased by 1,236% from 2020 to 2023, rising from 11 excess deaths… in 2020 to 147 excess deaths… in 2023. A quadratic increase in excess cardiopulmonary arrest mortality was observed with higher COVID-19 vaccination rates.”
May 27 – A study is published in Nature titled, “Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England.” Regarding the “risks of pre-specified safety outcomes following COVID-19 vaccination in adolescents aged 12–17 years,” the results section reads in part, “In the 1-42 days after the first and second doses of BNT162b2 [Pfizer], we observed an increased risk of myocarditis in adolescents aged 12–17 years… We estimated that an additional 3 cases per million exposed would be anticipated after the first dose and 5 after the second dose… There was also an increased risk of hospitalisation with epilepsy (excess events per million: 12) in the 1-42 days following the second dose of BNT162b2… In the sex-stratified analysis, the increased risk of myocarditis after the first dose of BNT162b2 was only observed in females (excess events per million: 3), while the increased risk following the second dose was observed in males only (excess events per million: 9)… We additionally observed an increased risk of demyelinating disease, restricted to females (excess events per million: 4) following the second dose of BNT162b2. Of the eight female adolescents who experienced demyelinating disease in the 1-42 days following a second dose of BNT162b2, five were coded as optic neuritis… There was an increased risk of hospitalisation with epilepsy 1-42 days after a first dose of ChAdOX1 [AstraZeneca], with an additional 705… cases expected per million exposed. This increased risk was restricted to females in the sex-stratified analysis… with an additional 813… hospitalisations with epilepsy expected per million female adolescents exposed… We also observed an increased risk of appendicitis in the 1-42 days following the second dose of ChAdOX1 (excess events per million: 512).” Despite this data, however, the last sentence of the discussion section reads: “Overall, our findings support a favourable safety profile of COVID-19 vaccination using mRNA vaccines in children and young people aged 5-17 years.” Unless it’s your child who is maimed or killed, of course. Moreover, the study does not take into account injuries or outcomes other than the “pre-specified safety outcomes,” or the fact that the overwhelming majority of adverse vaccine reactions are never reported.
June 10 – A review published in the British Medical Journal analyzed 53 studies “to synthesise the existing literature on the relationship between COVID-19 vaccination and menstrual health outcomes.” According to the results, “the bulk of the literature demonstrates that [the] COVID-19 vaccine is associated with temporary changes in menstrual characteristics (cycle length and flow) and menstrual pain.” The conclusion reads in part, “we found evidence supporting an association between the COVID-19 vaccine and menstrual health outcomes. Given the importance of menstrual function to overall health, we recommend that all future vaccine trials include menstruation as a study outcome.” I highly doubt anything of the sort will ever take place.
June 13 – According to a study published in Cell, the climate crazies are now claiming “hot days reduce politicians’ language complexity, but not cold days… The findings propose that political rhetoric is not only driven by political circumstances and strategic concerns but also by physiological responses to external environmental factors. Overall, the study holds important implications on how climate change could affect human cognitive performance and the quality of political discourse.” After analyzing seven million parliamentary speeches, the leftists who produced the study claim – among other things – that, “Looking at long term developments, studies indicate that language complexity of political language has steadily decreased over the past 200 years. Furthermore, concerns are often brought forward in connection to rising populist movements and prominent populist leaders, who allegedly use less complex political language in order to strategically appeal to and manipulate their voters. Studies provided evidence for populists’ use of simpler political language and for the consequences of less complex language on voters. Further evidence shows that linguistic habits can be dependent on personality traits and political ideology of speakers. A study analyzing parliamentary speeches from different European countries and European prime ministers shows that speakers from culturally liberal parties use more complex language than speakers from culturally conservative parties.” Based on what I see and hear with my own eyes and ears here in America I am going to have to disagree with this dopey theory. There are many politicians on both sides of the aisle who sound dumber than a box of rocks whenever they open their mouths, and who I have criticized routinely in this timeline. They happily regurgitate weak talking points, refuse to acknowledge facts that don’t comport with their agenda-driven narratives and lie incessantly. It’s now just a matter of time before leftists everywhere begin pounding their fists on the table and loudly proclaiming it’s a scientific fact that liberals are smarter than conservatives. I mean, they pretty much do this already (remember how the left falsely claimed they were the party of science throughout the scamdemic?), but now they are producing nonsensical research to back up their false claims the same way they do with climate science… If you could use a laugh right about now, check out this hilarious video from The Babylon Bee.
June 18 – A preprint study is published online titled, “COVID-19 Vaccines: A Risk Factor for Cerebral Thrombotic Syndromes.” According to the results, there were “5,137 cerebral thromboembolism AEs [adverse events] reported in the 3 years (36 months) after COVID-19 vaccines compared to 52 AEs for the influenza vaccines over the past 34 years (408 months) and 282 AEs for all other vaccines (excluding COVID-19) over the past 34 years (408 months). The PRR’s [proportional reporting ratio] are significant when comparing AEs by time from COVID-19 vaccines to that of the influenza vaccines (p < 0.0001) or to that of all other vaccines (p < 0.0001). The CTE [cerebral thromboembolism] AEs PRR by time (95% confidence intervals) for the COVID-19 vaccine AEs vs influenza AEs is 1,120… and for COVID-19 vaccines vs all others is 207… Cerebral venous thromboembolism AEs are female predominant with a female/male odds ratio of 1.63… Conversely, cerebral arterial thromboembolism has a nonsignificant male preponderance. Cerebral venous thromboembolism is far more common than cerebral arterial thromboembolism over 36 months with an odds ratio (OR) of 14.8… Atrial fibrillation, the most common identifiable cause of cerebral arterial thromboembolism, occurs far more commonly after the COVID-19 as compared to all other vaccines with a PRR of 123…” The study’s conclusion reads, “There is an alarming breach in the safety signal threshold concerning cerebral thrombosis AEs after COVID-19 vaccines compared to that of the influenza vaccines and even when compared to that of all other vaccines. An immediate global moratorium on the use of COVID-19 vaccines is necessary with an absolute contraindication in women of reproductive age.”
June 21 – After being censored by The Lancet, a study conducted by doctors Peter McCullough, Paul Alexander, Harvey Risch, William Makis and others has finally been peer-reviewed and published in Forensic Science International. The study reviewed 44 papers that “contained 325 autopsy cases and one necropsy case. The mean age of death was 70.4 years. The most implicated organ system among cases was the cardiovascular (49%), followed by hematological (17%), respiratory (11%), and multiple organ systems (7%). Three or more organ systems were affected in 21 cases. The mean time from vaccination to death was 14.3 days. Most deaths occurred within a week from [the] last vaccine administration. A total of 240 deaths (73.9%) were independently adjudicated as directly due to or significantly contributed to by COVID-19 vaccination, of which the primary causes of death include sudden cardiac death (35%), pulmonary embolism (12.5%), myocardial infarction (12%), VITT (7.9%), myocarditis (7.1%), multisystem inflammatory syndrome (4.6%), and cerebral hemorrhage (3.8%).” No wonder The Lancet wanted nothing to do with it…